Literature DB >> 28464487

A novel Xp22.13 microdeletion in Nance-Horan syndrome.

Andrea Accogli1,2, Monica Traverso1,2, Francesca Madia1, Tommaso Bellini1,2, Maria Stella Vari1, Francesca Pinto1, Valeria Capra1.   

Abstract

BACKGROUND: Nance-Horan syndrome (NHS) is a rare X-linked developmental disorder characterized by congenital cataract, dental anomalies and facial dysmorphisms. Notably, up to 30% of NHS patients have intellectual disability and a few patients have been reported to have congenital cardiac defects. Nance-Horan syndrome is caused by mutations in the NHS gene that is highly expressed in the midbrain, retina, lens, tooth, and is conserved across vertebrate species. Although most pathogenic mutations are nonsense mutations, a few genomic rearrangements involving NHS locus have been reported, suggesting a possible pathogenic role of the flanking genes.
METHODS: Here, we report a microdeletion of 170,6 Kb at Xp22.13 (17.733.948-17.904.576) (GRCh37/hg19), detected by array-based comparative genomic hybridization in an Italian boy with NHS syndrome.
RESULTS: The microdeletion harbors the NHS, SCLML1, and RAI2 genes and results in a phenotype consistent with NSH syndrome and developmental delay.
CONCLUSION: We compare our case with the previous Xp22.13 microdeletions and discuss the possible pathogenetic role of the flanking genes. Birth Defects Research 109:866-868, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Nance-Horan syndrome; Xp22.13 microdeletion; cataract and teeth anomalies; developmental delay

Mesh:

Substances:

Year:  2017        PMID: 28464487     DOI: 10.1002/bdr2.1032

Source DB:  PubMed          Journal:  Birth Defects Res            Impact factor:   2.344


  6 in total

1.  A contiguous microdeletion syndrome at Xp23.13 with non-obstructive azoospermia and congenital cataracts.

Authors:  Aubrey Milunsky; Jeff M Milunsky; Weilai Dong; Hayk Hovhannisyan; Robert D Oates
Journal:  J Assist Reprod Genet       Date:  2020-01-09       Impact factor: 3.412

2.  A novel Nance-Horan syndrome mutation identified by next-generation sequencing in a Chinese family.

Authors:  Hong-Yan Sun; Hong-Jing Zhu; Ru-Xu Sun; Ying Wang; Jia-Nan Wang; Bing Qin; Wei-Wei Zhang; Jiang-Dong Ji
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

3.  Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.

Authors:  Wenji Yan; Kongming Wu; James G Herman; Xiuduan Xu; Yunsheng Yang; Guanghai Dai; Mingzhou Guo
Journal:  Clin Epigenetics       Date:  2018-05-23       Impact factor: 6.551

4.  Fine Breakpoint Mapping by Genome Sequencing Reveals the First Large X Inversion Disrupting the NHS Gene in a Patient with Syndromic Cataracts.

Authors:  Alejandra Damián; Raluca Oancea Ionescu; Marta Rodríguez de Alba; Alejandra Tamayo; María José Trujillo-Tiebas; María Carmen Cotarelo-Pérez; Olga Pérez Rodríguez; Cristina Villaverde; Lorena de la Fuente; Raquel Romero; Gonzalo Núñez-Moreno; Pablo Mínguez; Carmen Ayuso; Marta Cortón
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

5.  Identification of a novel microdeletion causative of Nance-Horan syndrome.

Authors:  Mariana Lopez Martinolich; Hope Northrup; Pedro Mancias; Paul Hillman; Kavya Rao; Kate Mowrey
Journal:  Mol Genet Genomic Med       Date:  2022-02-05       Impact factor: 2.183

6.  Whole exome sequencing identified a novel truncation mutation in the NHS gene associated with Nance-Horan syndrome.

Authors:  Chao Ling; Ruifang Sui; Fengxia Yao; Zhihong Wu; Xue Zhang; Shuyang Zhang
Journal:  BMC Med Genet       Date:  2019-01-14       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.